Clinical trials
Observational Exanthema trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 5 |
| Terminated | 2 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Al-Azhar University | 1 |
| Ausnutria Hyproca B.V. | 1 |
| Bamrasnaradura Infectious Diseases Institute | 1 |
| Cairo University | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Chelsea and Westminster NHS Foundation Trust | 1 |
| Creighton University | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Hospital Israelita Albert Einstein | 1 |
| Istanbul University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Exanthema | 19 |
| Urticaria | 3 |
| Acquired Immunodeficiency Syndrome | 2 |
| Colorectal Neoplasms | 2 |
| Erythema | 2 |
| Hypersensitivity | 2 |
| Abscess | 1 |
| Angioedema | 1 |
| Atherosclerosis | 1 |
| Carcinoma, Hepatocellular | 1 |
Trials
Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.